Model
Edge
EyePoint Pharmaceuticals Inc.
0001736240
Filing type
4/A
Filing date
Aug 29, 2023
Updated
Aug 30, 2023 ยท 11:32 AM
Copy reference
Filing
4/A
Amended Statement of Changes in Beneficial Ownership